¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hudson's lactone rule"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lactone
    ¶ôÅæ
  • astigmatism against the rule
    µµ³­½Ã, °Å²Ü³­½Ã
  • astigmatism with the rule
    Á÷³­½Ã, ¹Ù¸¥³­½Ã
  • interval rule
    °£°Ý±ÔÄ¢
  • multi-rule technique
    ´ÙÁß±ÔÄ¢±â¹ý
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
  • production rule
    »êÃâ¿øÄ¢
  • pairing rule
    ¦Áþ±â¿øÄ¢
  • rule
    1. ¹ýÄ¢, ±ÔÄ¢ 2. ¿øÄ¢
  • sum rule
    ÇÕÀǹýÄ¢
  • shunting rule
    Áö¸§±æ¹ýÄ¢
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • astigmatism with the rule
    Á÷³­½Ã, ¹Ù¸¥³­½Ã
  • astigmatism against the rule
    µµ³­½Ã, °Å²Ü³­½Ã
  • rule
    ¹ýÄ¢, ±ÔÄ¢, ¿øÄ¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • astigmatism against the rule
    µµ³­½Ã, °Å²Ü³­½Ã
  • astigmatism with the rule
    Á÷³­½Ã, ¹Ù¸¥³­½Ã
  • interval rule
    °£°Ý±ÔÄ¢
  • multi-rule technique
    ´ÙÁß±ÔÄ¢¹ý
  • pairing rule
    ¦Áþ±â¿øÄ¢
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
  • production rule
    »êÃâ¿øÄ¢
  • rule
    ¹ýÄ¢, ±ÔÄ¢, ¿øÄ¢
  • shunting rule
    Áö¸§±æ¹ýÄ¢
  • sum rule
    ÇÕÀDZÔÄ¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hudson-Staehli line
    Çãµå½¼-½ºÅŸ®¼±
  • Knaps rule
    ³À¾¾¹ýÄ¢
  • MNaghten (=McNaughten) rule
    ¸Æ³ëư ±ÔÄ¢
  • McNaghten Rule
    ¸Æ³ëư±ÔÄ¢
  • Prentices rule
    ÇÁ·»Æ¼½º¹ýÄ¢
  • Prince rule
    ÇÁ¸°½º¹ýÄ¢
  • Westgard multi rule technique
    ¿þ½ºÆ®°¡µå´Ù¿ø±ÔÄ¢¹ý
  • against-the-rule astigmatism
    µµ³­½Ã
  • phase rule
    »ó·ü(ßÓëÏ).
  • production rule
    »êÃâ¿øÄ¢<--¹ýÄ¢>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • against-the-rule astigmatism
    µµ³­½Ã
  • astigmatism against-the-rule
    µµ³­½Ã(ÓîÕ¯ãÊ).
  • astigmatism with-the-rule
    Á÷³­½Ã.
  • interval rule
    °£°Ý±ÔÄ¢(¡­Ð®öÎ).
  • multi-rule technique
    ´Ù¹ýÄ¢<´Ù±ÔÄ¢>±â¹ý
  • pairing rule
    ¦Áþ±â¿øÄ¢.
  • phase rule
    »ó·ü(ßÓëÏ).
  • production rule
    »êÃâ¿øÄ¢<--¹ýÄ¢>
  • rule for substitution
    ġȯ±ÔÄ¢(öÇüµÐ®öÎ).
  • rule of nines
    9 ¹ýÄ¢
  • sum rule
    ÇÕÀÇ ±ÔÄ¢(ùꡭЮöÎ).
  • with-the-rule astigmatism
    Á÷³­½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hudson's rule
    Çãµå½¼À²(ëÏ)
  • lactone rule
    ¶ôÅæ À²(ëÏ)
  • lactone
    ¶ôÅæ
  • Gibbs phase rule
    ±é½º À§»ó ¹ýÄ¢(êÈßÓÛööÎ)
  • GU-AG rule
    GU-AGÀ²(ëÏ)
  • isoprene rule
    ¾ÆÀ̼ÒÇÁ·» À²(×È)
  • isorotation rule
    µî±¤È¸Àü À²(ÔõÎÃüÞï®ëÏ)
  • Landsteinter's rule
    ¶õÆ®½ºÅ¸Àε¥¸£À²(×È)
  • nitrogen rule
    Áú¼Ò·ü(òòáÈ×È)
  • phase rule
    »óÀ²(ßÓëÏ)
  • propionate rule
    ÇÁ·ÎÇǿ»ê(ß«) À²(ëÏ)
  • rule of mutual exclusion
    »óÈ£¹èÁ¦À²(ßÓû»ÛÉð¶ëÏ)
  • rule of the ring
    °í¸®À²(ëÏ)
  • Schuetz-Borrisow rule
    ½´Ã÷-º¸¸®¼Ò¿ì À²(ëÏ)
  • Traube's rule
    Æ®¶ó¿ìº£À²(ëÏ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
GAL galactose; galactosyl; glucuronic acid lactone
RO radiation oncology; radiation output; ratio of; relative odds; renal osteodystrophy; reverse osmosis...
R/O rule out
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NPRM Notice of Proposed Rule Making
ATR against the rule
WTR with the rule
BEL Bromoenol lactone
CL Coriaria Lactone
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • astigmatism against-the-rule
    µµ³­½Ã
  • basic rule
    ±âº» ¿øÄ¢
  • Jackson's rule
    Àè½¼ ¹ýÄ¢
    °£Áú ¹ßÀÛ ÈÄ ´Ü¼øÇÑ ±â´ÉÀº º¹ÀâÇÑ ±â´Éº¸´Ù »¡¸® ȸº¹ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Hudson, Arthur Cyril <person> British ophthalmologist, 1875-1962.
See: Hudson-Stahli line.
(05 Mar 2000)
Hudson-Stahli line <clinical sign, ophthalmology> A brown, horizontal line across the lower third of the cornea, occasionally seen in the aged and also in association with corneal opacities.
(05 Mar 2000)
pantoyl lactone dehydrogenase <enzyme> An fmn-dependent enzyme that catalyses the formation of ketopantoyl lactone from l-(+)-pantoyl lactone; isolated from nocardia asteroides
Registry number: EC 1.1.99.-
(26 Jun 1999)
homoserine lactone The cyclic ester (i.e., the d-lactone) of homoserine; formed by the reaction of cyanogen bromide on methionyl residues in peptides and proteins.
(05 Mar 2000)
triacetic acid lactone lyase <enzyme> Non-hydrolytic; froms acetyl-CoA from triacetic acid lactone plus ATP plus CoA
Registry number: EC 4.2.99.-
Synonym: ATP tal
(26 Jun 1999)
lactone <chemistry> One of a series of organic compounds, regarded as anhydrides of certain hydroxy acids. In general, they are colourless liquids, having a weak aromatic odour. They are so called because the typical lactone is derived from lactic acid.
Source: Websters Dictionary
(01 Mar 1998)
6-phospho-d-glucono d-lactone An intermediate in the pentose phosphate pathway that is synthesised from d-glucose-6-phosphate.
(05 Mar 2000)
l-gulono-gamma-lactone The immediate precursor of ascorbic acid in those animals capable of ascorbic acid biosynthesis.
Synonym: dihydroascorbic acid, l-gulono-gamma-lactone.
L-gulonolactone oxidase, the enzyme catalyzing the conversion of l-gulonolactone and O2 to H2O2 and l-xylo-hexulonolactone, a precursor of ascorbic acid; absent in primates.
(05 Mar 2000)
Abegg's rule The tendency of the sum of the maximum positive and maximum negative valence of a particular element to equal 8; e.g., C may have a valence of +4 and -4, O of +6 and -2. Sometimes loosely stated as all atoms have the same number of valences, a consequence of the tendency of valence electron shells to be filled to 8.
(05 Mar 2000)
American Law Institute rule A test of criminal responsibility (1962): "a person is not responsible for criminal conduct if at the time of such conduct as a result of mental disease or defect he lacks substantial capacity either to appreciate the wrongfulness of his conduct or to conform his conduct to the requirements of law."
(05 Mar 2000)
astigmatism against the rule Astigmatism when the greater curvature or refractive power is in the horizontal meridian.
(05 Mar 2000)
astigmatism with the rule Astigmatism when the greater curvature or refractive power is in the vertical meridian.
(05 Mar 2000)
pair rule gene <molecular biology> A segmentation gene, expressed sequentially between gap genes and segment polarity genes. In development of Drosophila, a set of about 8 genes that are expressed only in alternate segments (odd or even) of the developing embryo. Loss of function mutants thus lack alternate segments.
Examples: even skipped (eve), fushi tarazu (ftz), hairy.
(18 Nov 1997)
Gibb's phase rule An expression of the relationships existing between systems in equilibrium: P + V = C + 2, where P is the number of phases, V the variance or degrees of freedom, and C the number of components; it also follows that the variance is, V = C + 2 -P. For H2O at its triple point, V = 1 + 2 -3 = 0, i.e., both temperature and pressure are fixed.
Synonym: Gibb's phase rule.
(05 Mar 2000)
Gloger's rule The rule or observation that the skin of a warm-blooded animal species tends to become darker in colour towards warmer climates at lower altitudes or lower latitudes, and to become lighter in colour towards colder climates at higher altitudes or higher latitudes.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hudson
    ´º¿åÁÖ¸¦ È帣´Â °­
  • Hudson Bay
    ij³ª´Ù ºÏºÎÀÇ Å« ¸¸
  • Hudson Institute
    Çãµå½¼ ¿¬±¸¼Ò(h,KahnÀÌ ¼³¸³(1961)ÇÑ ¹Ì·¡ ¿¹Ãø;ºÐ¼®À» ÇÏ´Â µÎ³ú Áý´Ü)
  • Hudson seal
    ¸ðÁ¶ ¹Ù´Ù Ç¥¹ü Åа¡Á×
  • rule
    ±ÔÄ¢,Áö¹è,¸í·É,Áö¹èÇÏ´Ù,ÅëÄ¡ÇÏ´Ù
  • rule of thumb
    °æÇè¿¡¼­ ¾òÀº ¹ýÄ¢
  • rule out
    ¹èÁ¦ÇÏ´Ù
  • Dillon's Rule
    (¹Ì¹ý)µô·ÐÀÇ ¿øÄ¢(Áö¹æ ÀÚġüÀÇ ±ÇÇÑÀº ÁÖÇå¹ý ¶Ç´Â ¹ý¿¡ ¸í±âµÈ °Í¿¡ ÇÑÇÑ´Ù´Â ¿øÄ¢)
  • Miranda rule
    (¹Ì)¹Ì·£´õ ÁØÄ¢(¿øÄ¢)(À§¹ý ¼öÁý Áõ°Å ¹èÁ¦ ¿øÄ¢)
  • Rozelle rule
    ·ÎÁ© ±Ô¾à(ÇÁ·Î ¸®±×¿¡¼­ÀÇ ¼±¼ö °è¾à ±ÔÄ¢ÀÇ Çϳª)
  • Rule,Britannia
    ºê¸®ÅÂÀ̾;ÅëÄ¡Ç϶ó(¿µ±¹ÀÇ ±¹°¡)
  • caliper rule
    ͏®ÆÛ½º ÀÚ
  • chain rule
    ¿¬¼â ¹ýÄ¢
  • civilian rule
    ¹ÎÁ¤
  • exclusionary rule
    (¹Ì¹ý)(À§¹ý ¼öÁý Áõ°Å)¹èÁ¦ÀÇ ¿øÄ¢
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á